Macular Microvasculature Density Changes in Anisometropic Amblyopic Eyes after Successful Treatment

Table 2

Macular vessel density in amblyopic and the normal control group before treatment.

Retinal region	Macular vessel density, mean ± SD (%)			value
	Amblyopic eyes	Fellow eyes	Control eyes	Amblyopia vs. fellow	Amblyopia vs. control	Fellow vs. control
SCP
Fovea	23.8 ± 4.8	24.6 ± 5.8	25.3 ± 5.5	0.200	0.111	0.474
Parafovea	49.0 ± 4.1	51.8 ± 2.2	51.7 ± 2.6	0.012	0.010	0.840
T	47.6 ± 4.6	50.8 ± 2.5	50.8 ± 2.8	0.003	0.002	0.980
S	50.3 ± 4.0	52.6 ± 2.9	52.4 ± 2.9	0.036	0.155	0.905
N	48.2 ± 4.4	51.2 ± 2.1	51.0 ± 3.4	0.015	0.057	0.914
I	50.2 ± 4.5	52.4 ± 2.7	52.7 ± 3.0	0.104	0.030	0.481
DCP
Fovea	32.1 ± 6.1	32.5 ± 6.5	34.2 ± 5.9	0.684	0.141	0.703
Parafovea	51.6 ± 4.3	52.9 ± 2.7	53.0 ± 3.7	0.221	0.289	0.265
T	52.0 ± 3.9	52.6 ± 3.5	53.2 ± 3.7	0.594	0.138	0.602
S	51.5 ± 5.2	53.1 ± 3.4	53.3 ± 3.8	0.213	0.188	0.183
N	52.7 ± 4.0	53.6 ± 2.5	53.6 ± 4.1	0.301	0.931	0.174
I	50.3 ± 5.0	52.3 ± 2.5	52.1 ± 0.1	0.094	0.264	0.330
FAZ (mm^2)	0.30 ± 0.11	0.31 ± 0.10	0.29 ± 0.11	0.530	0.285	0.681

SD: standard deviation; SCP: superficial capillary plexus; T: temporal; S: superior; N: nasal; I: inferior; DCP: deep capillary plexus; FAZ: foveal avascular zone.